nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Vertigo—Altretamine—ovarian cancer	0.0235	0.0235	CcSEcCtD
Polythiazide—Leukopenia—Altretamine—ovarian cancer	0.0234	0.0234	CcSEcCtD
Polythiazide—Hyperuricaemia—Chlorambucil—ovarian cancer	0.0229	0.0229	CcSEcCtD
Polythiazide—Blood uric acid increased—Chlorambucil—ovarian cancer	0.0216	0.0216	CcSEcCtD
Polythiazide—Thrombocytopenia—Altretamine—ovarian cancer	0.0209	0.0209	CcSEcCtD
Polythiazide—Anorexia—Altretamine—ovarian cancer	0.0203	0.0203	CcSEcCtD
Polythiazide—Hyperuricaemia—Melphalan—ovarian cancer	0.02	0.02	CcSEcCtD
Polythiazide—Vasculitis—Melphalan—ovarian cancer	0.019	0.019	CcSEcCtD
Polythiazide—Blood uric acid increased—Melphalan—ovarian cancer	0.0189	0.0189	CcSEcCtD
Polythiazide—Decreased appetite—Altretamine—ovarian cancer	0.0185	0.0185	CcSEcCtD
Polythiazide—Asthenia—Altretamine—ovarian cancer	0.0153	0.0153	CcSEcCtD
Polythiazide—Aplastic anaemia—Vinorelbine—ovarian cancer	0.0152	0.0152	CcSEcCtD
Polythiazide—Dizziness—Altretamine—ovarian cancer	0.0141	0.0141	CcSEcCtD
Polythiazide—Vomiting—Altretamine—ovarian cancer	0.0136	0.0136	CcSEcCtD
Polythiazide—Nausea—Altretamine—ovarian cancer	0.0127	0.0127	CcSEcCtD
Polythiazide—Cramp muscle—Topotecan—ovarian cancer	0.0124	0.0124	CcSEcCtD
Polythiazide—Jaundice—Chlorambucil—ovarian cancer	0.0116	0.0116	CcSEcCtD
Polythiazide—Jaundice—Melphalan—ovarian cancer	0.0101	0.0101	CcSEcCtD
Polythiazide—Pancreatitis—Vinorelbine—ovarian cancer	0.00996	0.00996	CcSEcCtD
Polythiazide—Agitation—Chlorambucil—ovarian cancer	0.00854	0.00854	CcSEcCtD
Polythiazide—Agranulocytosis—Vinorelbine—ovarian cancer	0.00845	0.00845	CcSEcCtD
Polythiazide—Leukopenia—Chlorambucil—ovarian cancer	0.00832	0.00832	CcSEcCtD
Polythiazide—Muscle spasms—Topotecan—ovarian cancer	0.00795	0.00795	CcSEcCtD
Polythiazide—Glycosuria—Epirubicin—ovarian cancer	0.00768	0.00768	CcSEcCtD
Polythiazide—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00742	0.00742	CcSEcCtD
Polythiazide—Leukopenia—Topotecan—ovarian cancer	0.0074	0.0074	CcSEcCtD
Polythiazide—Leukopenia—Melphalan—ovarian cancer	0.00725	0.00725	CcSEcCtD
Polythiazide—Anorexia—Chlorambucil—ovarian cancer	0.00723	0.00723	CcSEcCtD
Polythiazide—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00722	0.00722	CcSEcCtD
Polythiazide—Cramp muscle—Paclitaxel—ovarian cancer	0.00712	0.00712	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—ovarian cancer	0.00711	0.00711	CcSEcCtD
Polythiazide—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00708	0.00708	CcSEcCtD
Polythiazide—Hyperuricaemia—Epirubicin—ovarian cancer	0.00671	0.00671	CcSEcCtD
Polythiazide—Pancreatitis—Paclitaxel—ovarian cancer	0.0067	0.0067	CcSEcCtD
Polythiazide—Thrombocytopenia—Topotecan—ovarian cancer	0.00661	0.00661	CcSEcCtD
Polythiazide—Decreased appetite—Chlorambucil—ovarian cancer	0.00659	0.00659	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00655	0.00655	CcSEcCtD
Polythiazide—Thrombocytopenia—Melphalan—ovarian cancer	0.00647	0.00647	CcSEcCtD
Polythiazide—Anorexia—Topotecan—ovarian cancer	0.00643	0.00643	CcSEcCtD
Polythiazide—Vertigo—Vinorelbine—ovarian cancer	0.00636	0.00636	CcSEcCtD
Polythiazide—Blood uric acid increased—Epirubicin—ovarian cancer	0.00634	0.00634	CcSEcCtD
Polythiazide—Leukopenia—Vinorelbine—ovarian cancer	0.00633	0.00633	CcSEcCtD
Polythiazide—Anorexia—Melphalan—ovarian cancer	0.0063	0.0063	CcSEcCtD
Polythiazide—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00623	0.00623	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—ovarian cancer	0.00621	0.00621	CcSEcCtD
Polythiazide—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00616	0.00616	CcSEcCtD
Polythiazide—Orthostatic hypotension—Docetaxel—ovarian cancer	0.00612	0.00612	CcSEcCtD
Polythiazide—Paraesthesia—Topotecan—ovarian cancer	0.00606	0.00606	CcSEcCtD
Polythiazide—Cramp muscle—Docetaxel—ovarian cancer	0.00603	0.00603	CcSEcCtD
Polythiazide—Urticaria—Chlorambucil—ovarian cancer	0.00602	0.00602	CcSEcCtD
Polythiazide—Paraesthesia—Melphalan—ovarian cancer	0.00594	0.00594	CcSEcCtD
Polythiazide—Decreased appetite—Topotecan—ovarian cancer	0.00587	0.00587	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—ovarian cancer	0.00586	0.00586	CcSEcCtD
Polythiazide—Aplastic anaemia—Epirubicin—ovarian cancer	0.00584	0.00584	CcSEcCtD
Polythiazide—Constipation—Topotecan—ovarian cancer	0.00577	0.00577	CcSEcCtD
Polythiazide—Decreased appetite—Melphalan—ovarian cancer	0.00575	0.00575	CcSEcCtD
Polythiazide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00565	0.00565	CcSEcCtD
Polythiazide—Hypersensitivity—Chlorambucil—ovarian cancer	0.00559	0.00559	CcSEcCtD
Polythiazide—Anorexia—Vinorelbine—ovarian cancer	0.0055	0.0055	CcSEcCtD
Polythiazide—Asthenia—Chlorambucil—ovarian cancer	0.00544	0.00544	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00541	0.00541	CcSEcCtD
Polythiazide—Urticaria—Topotecan—ovarian cancer	0.00536	0.00536	CcSEcCtD
Polythiazide—Urticaria—Melphalan—ovarian cancer	0.00525	0.00525	CcSEcCtD
Polythiazide—Diarrhoea—Chlorambucil—ovarian cancer	0.00519	0.00519	CcSEcCtD
Polythiazide—Paraesthesia—Vinorelbine—ovarian cancer	0.00519	0.00519	CcSEcCtD
Polythiazide—Photosensitivity—Epirubicin—ovarian cancer	0.00515	0.00515	CcSEcCtD
Polythiazide—Vascular purpura—Epirubicin—ovarian cancer	0.00505	0.00505	CcSEcCtD
Polythiazide—Jaundice—Docetaxel—ovarian cancer	0.00503	0.00503	CcSEcCtD
Polythiazide—Decreased appetite—Vinorelbine—ovarian cancer	0.00502	0.00502	CcSEcCtD
Polythiazide—Hypersensitivity—Topotecan—ovarian cancer	0.00497	0.00497	CcSEcCtD
Polythiazide—Constipation—Vinorelbine—ovarian cancer	0.00494	0.00494	CcSEcCtD
Polythiazide—Hypersensitivity—Melphalan—ovarian cancer	0.00487	0.00487	CcSEcCtD
Polythiazide—Asthenia—Topotecan—ovarian cancer	0.00484	0.00484	CcSEcCtD
Polythiazide—Vomiting—Chlorambucil—ovarian cancer	0.00482	0.00482	CcSEcCtD
Polythiazide—Agranulocytosis—Docetaxel—ovarian cancer	0.00482	0.00482	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—ovarian cancer	0.00476	0.00476	CcSEcCtD
Polythiazide—Asthenia—Melphalan—ovarian cancer	0.00474	0.00474	CcSEcCtD
Polythiazide—Purpura—Epirubicin—ovarian cancer	0.00469	0.00469	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—ovarian cancer	0.00467	0.00467	CcSEcCtD
Polythiazide—Diarrhoea—Topotecan—ovarian cancer	0.00462	0.00462	CcSEcCtD
Polythiazide—Urticaria—Vinorelbine—ovarian cancer	0.00459	0.00459	CcSEcCtD
Polythiazide—Muscle spasms—Paclitaxel—ovarian cancer	0.00458	0.00458	CcSEcCtD
Polythiazide—Diarrhoea—Melphalan—ovarian cancer	0.00452	0.00452	CcSEcCtD
Polythiazide—Nausea—Chlorambucil—ovarian cancer	0.0045	0.0045	CcSEcCtD
Polythiazide—Dizziness—Topotecan—ovarian cancer	0.00446	0.00446	CcSEcCtD
Polythiazide—Agitation—Paclitaxel—ovarian cancer	0.00437	0.00437	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—ovarian cancer	0.00434	0.00434	CcSEcCtD
Polythiazide—Vomiting—Topotecan—ovarian cancer	0.00429	0.00429	CcSEcCtD
Polythiazide—Vertigo—Paclitaxel—ovarian cancer	0.00428	0.00428	CcSEcCtD
Polythiazide—Leukopenia—Paclitaxel—ovarian cancer	0.00426	0.00426	CcSEcCtD
Polythiazide—Rash—Topotecan—ovarian cancer	0.00426	0.00426	CcSEcCtD
Polythiazide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00425	0.00425	CcSEcCtD
Polythiazide—Dermatitis—Topotecan—ovarian cancer	0.00425	0.00425	CcSEcCtD
Polythiazide—Headache—Topotecan—ovarian cancer	0.00423	0.00423	CcSEcCtD
Polythiazide—Vomiting—Melphalan—ovarian cancer	0.0042	0.0042	CcSEcCtD
Polythiazide—Rash—Melphalan—ovarian cancer	0.00417	0.00417	CcSEcCtD
Polythiazide—Dermatitis—Melphalan—ovarian cancer	0.00416	0.00416	CcSEcCtD
Polythiazide—Asthenia—Vinorelbine—ovarian cancer	0.00414	0.00414	CcSEcCtD
Polythiazide—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00413	0.00413	CcSEcCtD
Polythiazide—Nausea—Topotecan—ovarian cancer	0.00401	0.00401	CcSEcCtD
Polythiazide—Diarrhoea—Vinorelbine—ovarian cancer	0.00395	0.00395	CcSEcCtD
Polythiazide—Nausea—Melphalan—ovarian cancer	0.00393	0.00393	CcSEcCtD
Polythiazide—Muscle spasms—Docetaxel—ovarian cancer	0.00388	0.00388	CcSEcCtD
Polythiazide—Pancreatitis—Epirubicin—ovarian cancer	0.00383	0.00383	CcSEcCtD
Polythiazide—Dizziness—Vinorelbine—ovarian cancer	0.00382	0.00382	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00382	0.00382	CcSEcCtD
Polythiazide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.0038	0.0038	CcSEcCtD
Polythiazide—Anorexia—Paclitaxel—ovarian cancer	0.0037	0.0037	CcSEcCtD
Polythiazide—Vomiting—Vinorelbine—ovarian cancer	0.00367	0.00367	CcSEcCtD
Polythiazide—Rash—Vinorelbine—ovarian cancer	0.00364	0.00364	CcSEcCtD
Polythiazide—Dermatitis—Vinorelbine—ovarian cancer	0.00364	0.00364	CcSEcCtD
Polythiazide—Headache—Vinorelbine—ovarian cancer	0.00362	0.00362	CcSEcCtD
Polythiazide—Leukopenia—Docetaxel—ovarian cancer	0.00361	0.00361	CcSEcCtD
Polythiazide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00356	0.00356	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—ovarian cancer	0.00354	0.00354	CcSEcCtD
Polythiazide—Hyperglycaemia—Epirubicin—ovarian cancer	0.00352	0.00352	CcSEcCtD
Polythiazide—Paraesthesia—Paclitaxel—ovarian cancer	0.00349	0.00349	CcSEcCtD
Polythiazide—Nausea—Vinorelbine—ovarian cancer	0.00343	0.00343	CcSEcCtD
Polythiazide—Jaundice—Epirubicin—ovarian cancer	0.00339	0.00339	CcSEcCtD
Polythiazide—Decreased appetite—Paclitaxel—ovarian cancer	0.00338	0.00338	CcSEcCtD
Polythiazide—Constipation—Paclitaxel—ovarian cancer	0.00332	0.00332	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.0033	0.0033	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00326	0.00326	CcSEcCtD
Polythiazide—Agranulocytosis—Epirubicin—ovarian cancer	0.00325	0.00325	CcSEcCtD
Polythiazide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00322	0.00322	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—ovarian cancer	0.00314	0.00314	CcSEcCtD
Polythiazide—Anorexia—Docetaxel—ovarian cancer	0.00314	0.00314	CcSEcCtD
Polythiazide—Urticaria—Paclitaxel—ovarian cancer	0.00309	0.00309	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—ovarian cancer	0.00301	0.00301	CcSEcCtD
Polythiazide—Paraesthesia—Docetaxel—ovarian cancer	0.00296	0.00296	CcSEcCtD
Polythiazide—Decreased appetite—Docetaxel—ovarian cancer	0.00286	0.00286	CcSEcCtD
Polythiazide—Hypersensitivity—Paclitaxel—ovarian cancer	0.00286	0.00286	CcSEcCtD
Polythiazide—Constipation—Docetaxel—ovarian cancer	0.00282	0.00282	CcSEcCtD
Polythiazide—Asthenia—Paclitaxel—ovarian cancer	0.00279	0.00279	CcSEcCtD
Polythiazide—Diarrhoea—Paclitaxel—ovarian cancer	0.00266	0.00266	CcSEcCtD
Polythiazide—Muscle spasms—Epirubicin—ovarian cancer	0.00262	0.00262	CcSEcCtD
Polythiazide—Dizziness—Paclitaxel—ovarian cancer	0.00257	0.00257	CcSEcCtD
Polythiazide—Agitation—Epirubicin—ovarian cancer	0.0025	0.0025	CcSEcCtD
Polythiazide—Vomiting—Paclitaxel—ovarian cancer	0.00247	0.00247	CcSEcCtD
Polythiazide—Rash—Paclitaxel—ovarian cancer	0.00245	0.00245	CcSEcCtD
Polythiazide—Dermatitis—Paclitaxel—ovarian cancer	0.00245	0.00245	CcSEcCtD
Polythiazide—Vertigo—Epirubicin—ovarian cancer	0.00244	0.00244	CcSEcCtD
Polythiazide—Leukopenia—Epirubicin—ovarian cancer	0.00244	0.00244	CcSEcCtD
Polythiazide—Headache—Paclitaxel—ovarian cancer	0.00243	0.00243	CcSEcCtD
Polythiazide—Hypersensitivity—Docetaxel—ovarian cancer	0.00243	0.00243	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—ovarian cancer	0.00242	0.00242	CcSEcCtD
Polythiazide—Asthenia—Docetaxel—ovarian cancer	0.00236	0.00236	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—ovarian cancer	0.00231	0.00231	CcSEcCtD
Polythiazide—Nausea—Paclitaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—ovarian cancer	0.00226	0.00226	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—ovarian cancer	0.00225	0.00225	CcSEcCtD
Polythiazide—Diarrhoea—Docetaxel—ovarian cancer	0.00225	0.00225	CcSEcCtD
Polythiazide—Dizziness—Docetaxel—ovarian cancer	0.00218	0.00218	CcSEcCtD
Polythiazide—Thrombocytopenia—Epirubicin—ovarian cancer	0.00217	0.00217	CcSEcCtD
Polythiazide—Anorexia—Epirubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Polythiazide—Vomiting—Docetaxel—ovarian cancer	0.00209	0.00209	CcSEcCtD
Polythiazide—Rash—Docetaxel—ovarian cancer	0.00208	0.00208	CcSEcCtD
Polythiazide—Dermatitis—Docetaxel—ovarian cancer	0.00207	0.00207	CcSEcCtD
Polythiazide—Headache—Docetaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00201	0.00201	CcSEcCtD
Polythiazide—Paraesthesia—Epirubicin—ovarian cancer	0.00199	0.00199	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—ovarian cancer	0.00196	0.00196	CcSEcCtD
Polythiazide—Nausea—Docetaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Polythiazide—Decreased appetite—Epirubicin—ovarian cancer	0.00193	0.00193	CcSEcCtD
Polythiazide—Constipation—Epirubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—ovarian cancer	0.00184	0.00184	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—ovarian cancer	0.00179	0.00179	CcSEcCtD
Polythiazide—Urticaria—Epirubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Polythiazide—Hypersensitivity—Epirubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—ovarian cancer	0.00163	0.00163	CcSEcCtD
Polythiazide—Asthenia—Epirubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Polythiazide—Diarrhoea—Epirubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Polythiazide—Dizziness—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Polythiazide—Vomiting—Epirubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Rash—Epirubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Polythiazide—Dermatitis—Epirubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Polythiazide—Headache—Epirubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Polythiazide—Nausea—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Polythiazide—Rash—Doxorubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Polythiazide—Headache—Doxorubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
